Results 261 to 270 of about 481,186 (302)
Some of the next articles are maybe not open access.
Cervicovaginal lavage fluid zinc level as a marker of vaginal atrophy.
Menopause, 2020OBJECTIVES This study aimed to investigate the correlation between cervicovaginal fluid zinc levels and participants' menopausal status and the presence of vulvovaginal symptoms of genitourinary syndrome of menopause.
Péter Damjanovich +5 more
semanticscholar +1 more source
The journal of obstetrics and gynaecology research, 2020
To evaluate the efficacy and safety of 25 μg of estradiol gel on postmenopausal vaginal tissue.
P. Tanmahasamut +5 more
semanticscholar +1 more source
To evaluate the efficacy and safety of 25 μg of estradiol gel on postmenopausal vaginal tissue.
P. Tanmahasamut +5 more
semanticscholar +1 more source
The Detection and Management of Vaginal Atrophy
Journal of Obstetrics and Gynaecology Canada, 2004To support the practitioner in the diagnosis of vaginal atrophy and in the management of the related symptoms.The modalities of evaluation range from basic pelvic examination, examination of the vulva, and laboratory tests.A comprehensive approach to the detection of vaginal atrophy and a discussion of available therapeutic and nontherapeutic options ...
Shawna L, Johnston +8 more
openaire +2 more sources
Ospemifene in clinical practice for vulvo-vaginal atrophy: results at 3 months of follow-up of use
Gynecological Endocrinology, 2020Objective To assess the effect of ospemifene 60 mg/day in vulvovaginal atrophy (VVA) in postmenopausal women under conditions of routine clinical practice after 3 months of follow-up.
Carmen Pingarrón +5 more
semanticscholar +1 more source
Treatment of postmenopausal vaginal atrophy with 10-µg estradiol vaginal tablets
Menopause International, 2012Postmenopausal estrogen deficiency can lead to symptoms of urogenital atrophy. Individuals with urogenital atrophy have symptoms that include vaginal dryness, vaginal and vulval irritation, vaginal soreness, pain and burning during urination (dysuria), increased vaginal discharge, vaginal odour, vaginal infections, recurrent urinary tract infections ...
Nick, Panay, Ricardo, Maamari
openaire +2 more sources
Emerging therapies for postmenopausal vaginal atrophy
Maturitas, 2013Symptoms related to vaginal atrophy are a significant problem for postmenopausal women and estrogen has been the gold standard for its treatment. A number of recent reviews of vaginal estrogen products are available. This review will, therefore, focus on other products and potential products for this indication, including the tissue selective estrogen ...
openaire +2 more sources
European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2023
semanticscholar +1 more source
semanticscholar +1 more source
European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2022
O. D’Oria +7 more
semanticscholar +1 more source
O. D’Oria +7 more
semanticscholar +1 more source
Effects of Vulvovaginal Laser Therapy on Postmenopausal Vaginal Atrophy: A Prospective Study
Journal of gynecologic surgery, 2019Objective: About 45% of healthy postmenopausal women have symptoms related to vaginal atrophy that can affect quality of life, including self-esteem and relationships.
Priyanka Singh, C. Chong, How Chuan Han
semanticscholar +1 more source

